Bioascent Discovery Ltd.

bioascent enables drug discovery innovation; increasing lead finding opportunities through access to new chemical space; and providing compound management and logistics services that increase the value of existing collections. we deliver access to new, diverse compound collections through: - customisable access to the bioascent lead like, medicinal chemist selected, compound collection, where we can offer computational selection and rapid cherry picking to create focused screening sets, particularly suited to high value assays, such as cell based or phenotypic screens. - facilitating the secure sharing of partner compound collections, using our storage and it systems, under collaborator specific terms, between pharma, biotech and academic institutions; giving access to new chemistry space from high quality, drug like libraries. we already successfully implement the sharing of the joint european compound collection (jecc), composed of libraries supplied by 7 european pharma partners